Security Snapshot

IDEXX LABORATORIES INC /DE - Common Stock (IDXX) Institutional Ownership

CUSIP: 45168D104

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

1,057

Shares (Excl. Options)

53.51MFull value: 53,511,545 · shares · 30 Sep 2026

Price

$522.19

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.03%
Share change
+805,438
Value change
+$409,244,085
Number of holders
1,057
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
78,858,571
SEC-reported price per share
$527.07
Insider filing price
$527.07
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • IDXX - IDEXX LABORATORIES INC /DE - Common Stock is tracked under CUSIP 45168D104.
  • 1057 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1,311 to 1,057 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $39.12BFull value: $39,118,518,700 · USD · 30 Jun 2026
    to
    $28.04BFull value: $28,040,665,325 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1057 institutions filings for Q3 2026.

Open SEC evidence

Security key

45168D104

13F reference period

Q3 2026

13F holders

1,057

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
IDXX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.4% $3,297,923,861 7,599,078 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $3,358,119,852 5,976,472 Vanguard Capital Management 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5% $2,075,429,534 3,974,472 Vanguard Portfolio Management 30 Sep 2026
As of 30 Sep 2026, 1,057 institutional investors reported holding
53.51MFull value: 53,511,545 · shares · 30 Sep 2026
shares of IDEXX LABORATORIES INC /DE - Common Stock (IDXX). This represents 68% of the company’s total
78.86MFull value: 78,858,571 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
40%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 5,156,914 0.06% $2,692,888,922
VANGUARD PORTFOLIO MANAGEMENT LLC 5% 3,955,927 0.09% $2,065,745,520
STATE STREET CORP 4.8% 3,761,362 0.06% $1,964,145,623
Invesco Ltd. 4.3% 3,373,663 0.14% $1,761,692,874
GEODE CAPITAL MANAGEMENT, LLC 3.3% 2,620,703 0.07% $1,365,439,733
BAMCO INC /NY/ 2.3% 1,782,502 1.6% $930,804,719
GOLDMAN SACHS GROUP INC 1.5% 1,176,638 0.07% $614,428,577
T. Rowe Price Investment Management, Inc. 1.3% 1,033,659 0.38% $539,767,000
BLAIR WILLIAM & CO/IL 1.1% 847,318 1.1% $442,461,156
Capital Research Global Investors 1% 791,295 0.06% $413,245,638
Fundsmith LLP 0.91% 714,883 2.9% $373,304,754
DIMENSIONAL FUND ADVISORS LP 0.8% 632,961 0.06% $330,568,030
Legal & General Group Plc 0.79% 619,724 0.07% $323,613,680
AustralianSuper Pty Ltd 0.72% 567,656 1.2% $296,424,287
BANK OF AMERICA CORP /DE/ 0.71% 563,369 0.02% $294,185,677
VANGUARD FIDUCIARY TRUST CO 0.58% 453,856 0.05% $236,999,065
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 0.51% 400,290 0.34% $208,998,394
POLEN CAPITAL MANAGEMENT LLC 0.5% 392,609 2.2% $205,016,196
CAPITAL COUNSEL LLC/NY 0.5% 390,801 7.9% $204,072,374
SCHRODER INVESTMENT MANAGEMENT GROUP 0.47% 371,556 0.14% $198,202,833
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.43% 341,573 0.07% $181,323,287
Holocene Advisors, LP 0.42% 333,865 0.42% $174,340,964
MONTRUSCO BOLTON INVESTMENTS INC. 0.4% 317,110 2.9% $165,591,671
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 0.39% 306,107 0.52% $159,846,014
BAILLIE GIFFORD & CO 0.37% 290,135 0.14% $151,505,596

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 53,511,545 $28,040,665,325 +$409,244,085 $522.19 1,057
2026 Q2 74,276,290 $39,118,518,700 +$1,352,499,238 $526.44 1,311
2026 Q1 71,648,515 $40,264,547,927 -$2,039,616,195 $561.89 1,317
2025 Q4 75,208,804 $51,721,905,948 -$104,100,300 $676.53 1,380
2025 Q3 72,156,674 $46,076,126,465 -$1,364,521,761 $638.89 1,294
2025 Q2 74,492,454 $39,944,909,126 +$622,390,438 $536.34 1,224
2025 Q1 73,764,672 $30,958,486,481 +$779,942,482 $419.95 1,129
2024 Q4 71,835,659 $29,724,021,447 -$973,691,253 $413.44 1,115
2024 Q3 72,771,836 $36,698,542,671 -$866,484,087 $505.22 1,105
2024 Q2 74,742,498 $36,407,539,797 +$1,194,076,623 $487.20 1,100
2024 Q1 72,528,628 $39,086,467,213 -$62,993,917 $539.93 1,141
2023 Q4 72,729,572 $40,349,913,998 -$603,765,389 $555.05 1,143
2023 Q3 74,019,658 $32,363,649,715 +$430,812,418 $437.27 1,056
2023 Q2 73,042,621 $36,667,385,940 +$94,841,652 $502.23 1,059
2023 Q1 72,713,915 $36,334,265,012 -$355,801,839 $500.08 1,046
2022 Q4 73,497,514 $30,011,391,318 +$172,319,687 $407.96 982
2022 Q3 73,626,131 $24,002,744,883 -$83,281,427 $325.80 900
2022 Q2 73,767,652 $25,881,144,178 +$454,367,814 $350.73 940
2022 Q1 72,572,264 $39,690,896,632 +$485,420,646 $547.06 1,013
2021 Q4 71,508,034 $47,013,671,922 -$115,610,874 $658.46 1,084
2021 Q3 71,564,445 $44,507,146,691 -$836,578,782 $621.90 1,055
2021 Q2 72,890,084 $46,029,916,801 +$144,499,493 $631.55 1,021
2021 Q1 72,631,314 $35,536,251,001 -$362,776,244 $489.31 1,004
2020 Q4 73,683,435 $36,820,146,126 +$237,064,045 $499.87 957
2020 Q3 73,270,641 $28,787,297,170 -$575,176,884 $393.11 835
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .